Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine skeptic and former presidential hopeful Robert F. Kennedy Jr. as his pick to lead the U.
Trump taps Robert F. Kennedy Jr., vaccine skeptic, to lead HHS
The nearly $2 trillion agency administers health-insurance programs for millions of Americans, approves medications and oversees vaccine safety.
Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job
Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F. Kennedy Jr. to head the Department of Health and Human Services, the top U.S. health agency.
Moderna And Other Vaccine Maker Stocks Tumble After Trump Taps RFK Jr. As HHS Head
RFK Jr. has developed a reputation as a vaccine skeptic and pushed conspiracy theories including one linking vaccines to autism, which has been refuted by multiple major health organizations.
Health stocks hit after Trump taps RFK Jr for top job
The US health secretary leads a huge agency overseeing everything from food safety to medical research and welfare programmes. Critics of Kennedy, commonly known by his initials RFK Jr, include many public health officials,
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
Shares in European vaccine makers tumbled after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Europe's vaccine makers fall as Trump picks RFK Jr to lead top US health agency
Shares in European vaccine-makers fell in early trade on Friday after U.S. President-elect Donald Trump said he had selected Robert F. Kennedy Jr., who has previously spread misinformation on vaccines,
Trump picks vaccine sceptic RFK Jr for health secretary
Donald Trump has picked vaccine sceptic and former independent presidential candidate Robert F Kennedy Jr as his health secretary, as the president-elect continues to build his new administration. Kennedy,
Inside Moderna’s Tech-Driven Culture: Insights From CIO Brad Miller
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
The Score: Spirit, Tesla, Moderna and More Stocks That Defined the Week
Big pharma stocks needed a shot in the arm after Donald Trump chose vaccine skeptic Robert F. Kennedy Jr. as health secretary ...
Moderna Shares Are Dipping Today: What's Going On?
Shares of Moderna Inc. (NASDAQ: MRNA) are trading lower after President-elect Donald Trump nominated Robert F. Kennedy Jr. to ...
Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now
We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...
Moderna sales get lift from early nod for newest COVID shot
The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...
Moderna, with aid of TBWA\Chiat\Day, is making mRNA science exciting & accessible
With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
Moderna, Pfizer Stocks Fall After Reports of RFK Jr. Nomination
Shares of vaccine-makers fell after reports that Donald Trump is expected to nominate vaccine skeptic Robert F. Kennedy Jr.
Moderna is a ‘show-me story’ heading into Q3 earnings
Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports
Vaccine maker Moderna's chief executive officer Stephane Bancel will vacate his role as the company's chief commercial ...
Moderna Stock Gains on Better-Than-Expected Covid-19 Vaccine Sales
Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...
These Stocks Moved the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More
Applied Materials tumbles after issuing a disappointing fiscal first-quarter outlook, Palantir is transferring its stock listing to the Nasdaq, and Tesla rises following a decline on worries President ...